QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.

To read this article, please click here.

Posted in

More RSI News

Emma Hartnett 2018 recipient of Center for Produce Safety (CPS) Research Award

October 11, 2018
RSI logo in white

CPS has recently announced 13 new research awards totaling a little over $2.6 million. The awards are for research projects directed at answering critical questions…

Read News Item

Best Practices for Consideration of the Effects of Climate Change in Project-Level Assessments

May 4, 2018
RSI logo in white

Risk Sciences International (RSI) is pleased to announce in collaboration with the Ontario Centre for Climate Impacts and Adaptation Resources (OCCIAR), the public release of…

Read News Item

Risks of anticholinergic drugs

May 2, 2018
RSI logo in white

Adverse effects of drugs among the elderly should be given special attention when considering a pharmacological intervention. Two recent papers using large electronic health records…

Read News Item

Dr. Emma Hartnett Selected for JEMRA Roster of Scientific Experts

April 19, 2018
RSI logo in white

RSI’s Emma Hartnett has been selected to be part of the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment (JEMRA) Roster of Experts for a…

Read News Item